Home » Breaking News, Disasters, Health, Manipulation, North America, Wars / Conflicts » Bill Gates: ‘SADLY, Omicron is a Vaccine to COVID-19 which provided Natural Immunity but Another Pandemic is Coming’
Posted by EU Times on Feb 19th, 2022 //
Bill Gates has expressed his sadness that Covid-19 variant Omicron is effectively a “type of vaccine” that provided billions of people around the world with a level of natural immunity against serious disease caused by Covid-19.
The disturbing comments were made by Gates at the 2022 Munich Security Conference where he was being interviewed on stage in front of a live audience. According to Gates, Omicron did a “better job” than Big Pharma at “getting out to the world population.”
But rather than being a cause for celebration, the natural immunity enjoyed by billions of people makes Gates “sad.”
“Sadly, the virus itself, particularly the variant called Omicron, is a type of vaccine, that is it creates both B-cell and T-cell immunity and it’s done a better job of getting out to the world population than we have with vaccines.” Bill Gates said.
“If you do surveys in African countries, you get well over 80% of people have been exposed to either the vaccine or to various variants,” Gates continued. “So what that does, it means the chance of serious disease, those risks are now dramatically reduced because of that infection exposure.”
“It’s sad, we didn’t a great job on therapeutics, only now two years in do we have a good therapeutic. Vaccines, it took us two years to be in over-supply. Today there are more vaccines than there are demand for vaccines. That wasn’t true. And next time we should make it instead of two years, we should make it like six months.”
“It took us a lot longer this time than it should of.”
Sounds like Covid was the trial run.
During the same interview, Gates declared that another pandemic is incoming.
“We’ll have another pandemic. It will be a different pathogen next time,” Gates promised.
Did you like this information? Then please consider making a donation or subscribing to our Newsletter.